Overweight & Obesity

Semaglutide reduces excess body fat in people with obesity

In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored ...

Medications

New drug molecule for treatment of atrial fibrillation

Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance—atrial fibrillation (AF). The ...

Cardiology

Potential new treatment for heart attack

Scientists have found a potential new drug for treating the heart damage caused by a heart attack by targeting the way the heart reacts to stress, according to new research published in the journal, Cell Stem Cell and part-funded ...

page 6 from 40